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Abstract
Aims—The purpose of this study was to determine the clinical significance of detecting microbial
footprints of ureaplasmas in amniotic fluid (AF) using specific primers for the polymerase chain
reaction (PCR) in patients presenting with cervical insufficiency.
Methods—Amniocentesis was performed in 58 patients with acute cervical insufficiency
(cervical dilatation, ≥1.5 cm) and intact membranes, and without regular contractions (gestational
age, 16–29 weeks). AF was cultured for aerobic and anaerobic bacteria as well as genital
mycoplasmas. Ureaplasmas (Ureaplasma urealyticum and Ureaplasma parvum) were detected by
PCR using specific primers. Patients were divided into three groups according to the results of AF
culture and PCR for ureaplasmas: those with a negative AF culture and a negative PCR (n=44),
those with a negative AF culture and a positive PCR (n = 10), and those with a positive AF culture
regardless of PCR result (n=4).
Results—1) Ureaplasmas were detected by PCR in 19.0% (11/58) of patients, by culture in 5.2%
(3/58), and by culture and/or PCR in 22.4% (13/58); 2) Among the 11 patients with a positive
PCR for ureaplasmas, the AF culture was negative in 91% (10/11); 3) Patients with a negative AF
culture and a positive PCR for ureaplasmas had a significantly higher median AF matrix
metalloproteinase-8 (MMP-8) concentration and white blood cell (WBC) count than those with a
negative AF culture and a negative PCR (P<0.001 and P<0.05, respectively); 4) Patients with a
positive PCR for ureaplasmas but a negative AF culture had a higher rate of spontaneous preterm
birth within two weeks of amniocentesis than those with a negative AF culture and a negative
PCR (P<0.05 after adjusting for gestational age at amniocentesis); 5) Of the patients who
delivered within two weeks of amniocentesis, those with a positive PCR for ureaplasmas and a
negative AF culture had higher rates of histologic amnionitis and funisitis than those with a
negative AF culture and a negative PCR (P<0.05 after adjusting for gestational age at
amniocentesis, for each); (6) However, no significant differences in the intensity of the intra-
amniotic inflammatory response and perinatal outcome were found between patients with a
positive AF culture and those with a negative AF culture and a positive PCR.
Conclusions—1) Cultivation techniques for ureaplasmas did not detect most cases of intra-
amniotic infection caused by these microorganisms (91% of cases with cervical insufficiency and
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microbial footprints for ureaplasmas in the amniotic cavity had a negative AF culture); 2) Patients
with a negative AF culture and a positive PCR assay were at risk for intra-amniotic and fetal
inflammation as well as spontaneous preterm birth.
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abortion; ureaplasmas
Introduction
Microbial invasion of the amniotic cavity is found frequently in patients with cervical
insufficiency [24, 37, 40] and is a risk factor for failure of cerclage [28, 37, 40],
chorioamnionitis [7, 37], preterm birth and adverse pregnancy outcome [37]. Ureaplasmas
(Ureaplasma urealyticum and Ureaplasma parvum) are the organisms most frequently
isolated from the amniotic fluid (AF) of patients with cervical insufficiency [24, 37].
However, the fastidious nature of these microorganisms requires special culture conditions
for isolation. One limitation of cultivation in clinical medicine is that this procedure takes
time, and results of the culture may not be available in time for clinical management
decisions. Moreover, the lack of a rigid cell wall of ureaplasmas, as well as their small size,
make these organisms non-detectable by Gram stain examination.
Recently, molecular microbiology techniques based upon the polymerase chain reaction
(PCR) have emerged as a sensitive and rapid method for the detection of ureaplasmas (U.
urealyticum and U. parvum) in clinical samples, including AF [12, 46, 49], secretions from
the urogenital tract [5, 39], tracheal aspirates [8, 41] and cerebrospinal fluid of preterm
neonates [42]. We previously demonstrated that a positive PCR assay for ureaplasmas, using
specific primers (regardless of culture results), is a powerful predictor of impending preterm
birth and adverse pregnancy outcome in patients with preterm premature rupture of
membranes (PROM) [46] or preterm labor with intact membranes [49]. The purpose of this
study was to determine the clinical significance of detecting microbial footprints for
ureaplasmas by PCR in the AF of patients with cervical insufficiency.
Material and methods
Study design
The study population consisted of 58 patients who were admitted to the participating
institution between January 1993 and December 2007 with the diagnosis of cervical
insufficiency (painless cervical dilatation) and singleton gestation, who underwent
amniocentesis for the assessment of microbiologic status of AF. The diagnosis of cervical
insufficiency was made in patients who met the following criteria: (1) progressive painless
cervical dilation (≥1.5 cm), (2) intact membranes, and (3) the absence of regular uterine
contractions. Gestational age ranged between 16 and 29 weeks. Cervical dilation was
determined by visual evaluation of the sterile speculum examination. Retrieval of AF was
performed after obtaining written informed consent. The Institutional Review Board of the
participating institution approved the collection and use of these samples and information
for research purposes. This University Hospital has a Federal Wide Assurance with the
Office for Human Research Protection of the Department of Health and Human Services of
the USA.
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AF was cultured for genital mycoplasmas (ureaplasmas [U. urealyticum and U. parvum] and
M. hominis) as well as aerobic and anaerobic bacteria. An aliquot of AF was examined in a
hemocytometer chamber to determine the white blood cell (WBC) count. The remaining
fluid was stored at −70°C until assayed. The stored AF was analyzed for matrix
metalloproteinase-8 (MMP-8), which was measured with a commercially available enzyme-
linked immunosorbent assay (Amersham Pharmacia Biotech, Inc, Bucks, UK), as previously
reported [24, 34]. The sensitivity of the test was 0.3 ng/mL. Intra- and inter-assay
coefficients for each were <10%.
PCR assay for ureaplasmas in AF
PCR assay for ureaplasmas (U. urealyticum and U. parvum) was performed with stored AF
according to methods previously described [46, 49]. Briefly, after thawing, a 50 μL aliquot
of AF was centrifuged (25,000×g for 10 min at 4°C). The pellet was resuspended in 15 μL
deionized water, and the solution was boiled for 10 min and quickly cooled on ice. After
centrifuge (25,000×g for 10 min at 4°C) of the solution, 5 μL of the supernatants were taken
for PCR assay. The primers chosen were in the urease gene: 5′-CAA TCT GCT CGT GAA
GTA TTA C-3′ (U5, forward) and 5′-ACG ACG TCC ATA AGC AAC T-3 (U4, reverse)
and the amplified product size was 429 base pair DNA fragments of all serotypes of
ureaplasmas (U. parvum and U. urealyticum) [2, 5, 41]. PCR assay was performed in a total
volume of 25 μL containing 0.6 pmol of each primer, 10 mM Tris-HCl (pH 8.3), 50 mM
KCl, 1.5 mM MgCl2, 0.16 mM dNTP, 1 unit Taq polymerase (Takara Bio Healthcare,
Shiga, Japan) and 5 μL extracted DNA template. The thermal cycling (PTC-200, MJ
research, Waltham, MA, USA) profile consisted of 94°C for 5 min, 35 cycles of
denaturation at 94°C for 1 min, annealing at 58°C for 1 min and elongation at 72°C for 1
min, and an extension at 72°C for 5 min. The amplified products were separated by
electrophoresis in 1.5% agarose gel (SeaKem LE agarose, Cambrex BioScience Rockland,
Rockland, ME, USA) at 150 V for 30 min.
Placental histologic examination and diagnosis of neonatal morbidity
Choriodeciduitis and amnionitis were defined in the presence of acute inflammatory changes
in chorion-decidua and amnion, respectively; funisitis was diagnosed in the presence of
neutrophil infiltration into umbilical vessel walls or Wharton's jelly with the use of criteria
previously published [44]. Significant neonatal morbidity was defined as the presence of any
of the following conditions: proven congenital neonatal sepsis, respiratory distress syndrome
(RDS), congenital pneumonia, bronchopulmonary dysplasia (BPD), intraventricular
hemorrhage (grade ≥II), and necrotizing enterocolitis. These conditions were diagnosed
according to definitions previously described in detail [47].
Statistical analysis
Proportions were compared with the Fisher's exact test. The Kruskal-Wallis analysis of
variance test was used for comparison of continuous variables among groups. Multiple
comparisons between groups were performed with the Mann-Whitney U-test. Logistic
regression analysis was performed to examine the relationship between positive PCR results
and the outcome of interest after adjusting for the effect of gestational age. Statistical
significance was defined as P<0.05.
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Amniotic fluid culture and PCR for ureaplasmas
The prevalence of a positive AF culture was 6.9% (4/58). Ureaplasmas were detected in
19.0% (11/58) by PCR, in 5.2% (3/58) by culture and in 22.4% (13/58) by culture and/or
PCR. Other microorganisms isolated by culture included Enterococcus sp. (n = 1),
Staphylococcus aureus (n = 1), and Streptococcus mitis (n = 1). One patient had three
organisms that were isolated from AF (Ureaplasma sp, Enterococcus sp, and S. aureus).
Table 1 shows the results of AF culture and PCR assay. Among the 11 patients with a
positive PCR for ureaplasmas, AF culture was negative in 90.9% (10/11).
Table 2 describes the clinical characteristics of the study population. There were no
significant differences in the clinical characteristics including age, parity, median gestational
age at amniocentesis, and the use of antenatal antibiotics and corticosteroids among the three
groups.
Intra-amniotic inflammatory response
Figure 1 displays the differences in AF MMP-8 concentrations and WBC counts according
to the results of AF culture and PCR for ureaplasmas. Patients with a negative AF culture
and a positive PCR (group 2) had a significantly higher median AF MMP-8 concentration
and WBC count than those with a negative AF culture and negative PCR (group 1) (P<0.05
and <0.001, respectively). However, there were no significant differences in the median AF
MMP-8 concentration and WBC count between patients with a negative AF culture and a
positive PCR (group 2) and those with a positive AF culture regardless of the PCR result
(group 3) (P>0.1 for each).
Pregnancy outcome
Tables 3 and 4 show the pregnancy and neonatal outcomes according to the results of AF
culture and PCR for ureaplasmas. Patients in group 2 had a significantly higher rate of
spontaneous delivery within two weeks of amniocentesis than those in group 1 (P <0.05
after adjusting for gestational age at amniocentesis). Of the patients who delivered within
two weeks of amniocentesis, patients in group 2 had higher rates of histologic amnionitis
and funisitis than those in group 1 (P <0.05 after adjusting for gestational age at
amniocentesis, for each). However, there were no significant differences in pregnancy and
neonatal outcomes between patients in groups 2 and 3 (P>0.1).
Patients with a negative culture but a positive PCR for ureaplasmas
Ten patients had a positive PCR for ureaplasmas but a negative AF culture. All patients
except one case delivered at 28 weeks of gestation or less and within two weeks of
amniocentesis. Serial amniocenteses revealed decreases in the AF WBC count (from 35 to 2
cells/mm3) and MMP-8 concentration (from 140.1 to 13.4 ng/mL) after the administration of
antibiotics for two weeks in that case. The AF WBC counts and MMP-8 concentrations were
elevated in all but one case, which had an AF WBC count of 2 cells/mm3, but an elevated
AF MMP-8 concentration of 107.1 ng/mL. The patient had a cerclage after the
amniocentesis, but subsequently ruptured her membranes and delivered prematurely.
Comment
Principal findings of this study
1) In patients with the clinical diagnosis of cervical insufficiency, ureaplasmas were detected
in 19.0% of patients by PCR alone, in 5.2% by culture alone, and 22.4% by either PCR and/
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or culture; 2) Cultivation techniques for genital mycoplasmas missed 91% of cases with
microbial invasion of the amniotic cavity with ureaplasmas demonstrated by molecular
microbiology techniques; 3) Patients with a positive PCR for ureaplasmas but a negative AF
culture had a more intense intra-amniotic inflammatory response reflected by the AF WBC
count and MMP-8 concentration than those with a negative culture and a negative PCR; 4)
Spontaneous preterm delivery within two weeks of amniocentesis occurred in 88% of
patients with a positive PCR for ureaplasmas but a negative culture; 5) Collectively, this
evidence indicates that the presence of microbial footprints for ureaplasmas in the absence
of a positive culture is a poor prognostic sign.
PCR assay for detecting ureaplasmas
The observation that microbial footprints for ureaplasmas are detected (using molecular
microbiology techniques) more frequently than the isolation of these organisms using
cultivation techniques is in keeping with those of other investigators [8, 26, 39, 46, 49]. The
advantages of a PCR-based assay for the detection of ureaplasmas include its sensitivity as
well as speed. The results of culture techniques may take several days, but the results of
PCR assays can be available within hours.
One potential problem of PCR-based assays is the difficulty of false-positive results
(positive PCR but negative culture). A false-positive result may be the consequence of a low
sensitivity of cultivation techniques or, alternatively, amplification of DNA from dead
bacteria or contamination. Contamination at the time of amniocentesis is unlikely, because
ureaplasmas are not normally found in the skin.
Our study demonstrated the importance of the detection of microbial footprints, even if
enough ureaplasmas are not present to yield a positive culture. This may occur not only
because the number of viable bacteria are small, but also because the bacteria present may
have limited viability as a consequence of attack by the innate or adaptive immune system.
Indeed, heat-inactivated Ureaplasma can stimulate human and rat macrophage cell lines to
produce pro-inflammatory cytokines [25]. An in vitro study demonstrated that microbial
products of Ureaplasma can stimulate the production of the inflammatory mediators by
explants of choriodecidual tissue [1]. We believe that such observations provide a link
between the detection of microbial footprints (despite negative cultures) and adverse
pregnancy outcome.
The results of the present study indicate that intra-amniotic infection with ureaplasmas
determined by PCR assay is associated with intra-amniotic/placental inflammation and
adverse pregnancy outcome, despite the failure of culture techniques to detect the presence
of the microorganism in patients with cervical insufficiency. Only one of ten patients with a
positive PCR but a negative AF culture delivered after 28 weeks of gestation and had an
amniocentesis-to-delivery interval of >2 weeks in the current study. However, we observed
decreases in AF WBC count and MMP-8 concentration with the use of antibiotics over the
following two weeks in that case. These observations are consistent with those reported by
Hassan et al. [17], indicating that antibiotic administration can eradicate ureaplasmas
detected by culture.
Intra-amniotic infection with ureaplasmas in cervical insufficiency
The prevalence of ureaplasmas by AF culture and/or PCR assay was 22.4% (13/58) in
patients with cervical insufficiency. One small study [6] reported that the detection rate of
this microorganism using PCR was 33.3% (5/15) in patients with cervical insufficiency.
Romero et al. [37] found an 18.1% (6/33) prevalence of ureaplasmas using culture
techniques in patients with cervical dilatation ≥2 cm with gestational age from 14 to 24
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weeks. These findings suggested that about a quarter of patients with cervical insufficiency
have intra-amniotic infection with ureaplasmas. This is somewhat higher than the prevalence
of ureaplasmas in other obstetrical conditions, such as preterm labor with intact membranes
[36, 49], a short cervix [17] and normal pregnancy at the time of genetic amniocentesis [12,
15, 35].
Whether ureaplasmas are present and lead to cervical insufficiency, or alternatively, whether
the organisms gain access to the amniotic cavity after the cervix is dilated and the
membranes exposed, remains to be determined.
Intra-amniotic inflammation without evidence of intra-amniotic infection in cervical
insufficiency
Intra-amniotic inflammation (regardless of the presence or absence of proven intra-amniotic
infection) is associated with adverse pregnancy outcome [9, 23, 38, 48]. Recent studies
revealed that various chemokines [11, 14, 16, 18, 21, 29, 30], as well as traditional
proinflammatory cytokines such as the interleukin family [3, 13, 19, 45] and MMPs [4, 10,
27, 32], play a role in the pathogenesis of intra-amniotic infection/inflammation and preterm
parturition. Our previous study [24] demonstrated a high prevalence of intra-amniotic
inflammation (defined as an elevated MMP-8 concentration) in cases of cervical
insufficiency, and its relationship with adverse pregnancy outcome. Other investigators [20]
reported significantly increased concentrations of AF inflammatory cytokines regardless of
proven AF infection in patients with a short cervix (≤5 mm). In the present study, we were
able to demonstrate that two-thirds of cases with a negative AF culture and a negative PCR
have histologic choriodeciduitis, which is not different from that of cases with proven intra-
amniotic infection (Table 3). This may be due to infections that escape detection with
standard cultivation techniques, or alternatively, that intra-amniotic infections develop after
the amniocenteses were performed. Another possibility is that extra-amniotic inflammation
without intra-amniotic infection plays a role in the occurrence of cervical insufficiency.
Other investigators [31] showed that extra-amniotic infection is much more frequent than
intra-amniotic infection. However, more studies are needed to clarify the association
between extra-amniotic inflammation and cervical insufficiency.
In contrast to the high prevalence of choriodeciduitis, amnionitis and funisitis were found in
only 20% of patients without evidence of intra-amniotic infection (by culture and PCR) that
is lower than the prevalence of 80% in those with a positive PCR but a negative culture
(Table 3). The amnion is the final barrier to reach the amniotic cavity and funisitis is a
marker of fetal inflammation. Involvement of the amnion and the umbilical cord is an
indicator of a fetal inflammatory response [33]. It is consistent with the finding of our
previous study [22] that patients with documented AF infection had a more intense fetal
inflammatory response than women with intra-amniotic inflammation without AF infection.
Such findings suggest that intra-amniotic infection with ureaplasmas, detected by PCR
assay, may be more frequently associated with a fetal inflammatory response syndrome and
adverse neonatal outcome than intra-amniotic inflammation with a negative culture and PCR
in patients with cervical insufficiency.
Neonatal outcome
Ureaplasmas have been implicated in the genesis of neonatal disease, such as BPD,
congenital pneumonia, bacteremia and meningitis [43]. In the present study, significant
neonatal morbidity was present in 80% of neonates with a positive PCR, but a negative
culture, but only in 42% of those with a negative PCR and a negative AF culture. This trend
did not reach statistical significance (Table 4); however, the power to detect a difference of
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38% between the two groups was only 27% in the present study, and therefore, this may be
the result of a type II error.
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Amniotic fluid (AF) matrix metalloproteinase-8 (MMP-8) concentrations and white blood
cell (WBC) counts according to the results of AF culture and polymerase chain reaction
(PCR) assay for ureaplasmas.
(A) AF MMP-8 concentrations (group 1: median, 51.4 ng/mL [range, 0.5–1801.4 ng/mL];
group 2: median, 178.4 ng/mL [range, 45.7–6142.6 ng/mL]; group 3: median, 547.3 ng/mL
[range, 129.1–770.6 ng/mL]; P<0.01 by Kruskal-Wallis analysis of variance test) and (B)
AF WBC counts (group 1: median, 3 cells/mm3 [range, 0–>1000 cells/mm3]; group 2:
median, 501 cells/mm3 [range, 2–>1000 cells/mm3]; group 3: median, 775 cells/mm3
[range, 62–>1000 cells/mm3]; P <0.001 by Kruskal-Wallis analysis of variance test).
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Table 1
Comparison of amniotic fluid (AF) culture and polymerase chain reaction (PCR) assay for ureaplasmas.
PCR result for ureaplasmas AF culture for ureaplasmas AF culture for all microorganisms
Positive Negative Positive Negative
Positive (n=11) 1 10 1 10
Negative (n=47) 2 45 3 44
Total (n=58) 3 55 4 54
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